COLL
Collegium Pharmaceutical, Inc. Healthcare - Drug Manufacturers - Specialty & Generic Investor Relations →
Collegium Pharmaceutical, Inc. (COLL) closed at $47.61 as of 2026-02-02, trading 64.0% above its 200-week moving average of $29.02. The stock moved further from the line this week, up from 59.0% last week. With a 14-week RSI of 76, COLL is in overbought territory.
Over the past 513 weeks of data, COLL has crossed below its 200-week moving average 14 times. On average, these episodes lasted 13 weeks. Historically, investors who bought COLL at the start of these episodes saw an average one-year return of +13.9%.
With a market cap of $1505 million, COLL is a small-cap stock. The company generates a free cash flow yield of 20.9%, which is notably high. Return on equity stands at 23.0%, indicating strong profitability. The stock trades at 5.5x book value.
The company has been aggressively buying back shares, reducing its share count by 6.6% over the past three years.
Over the past 9.9 years, a hypothetical investment of $100 in COLL would have grown to $250, compared to $393 for the S&P 500. COLL has returned 9.7% annualized vs 14.8% for the index, underperforming the broader market over this period.
Free cash flow has been growing at a 26% compound annual rate, with 4 consecutive years of positive cash generation.
Growth of $100: COLL vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After COLL Crosses Below the Line?
Across 14 historical episodes, buying COLL when it crossed below its 200-week moving average produced an average return of +12.0% after 12 months (median +31.0%), compared to +14.8% for the S&P 500 over the same periods. 64% of those episodes were profitable after one year. After 24 months, the average return was +40.4% vs +32.4% for the index.
Each line shows $100 invested at the moment COLL crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
COLL has crossed below its 200-week MA 14 times with an average 1-year return of +13.9% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Apr 2016 | Sep 2016 | 24 | 48.5% | -46.1% | +156.8% |
| Oct 2016 | Nov 2017 | 55 | 50.9% | -34.7% | +212.6% |
| Aug 2018 | Oct 2018 | 7 | 12.8% | -31.6% | +182.7% |
| Oct 2018 | Nov 2018 | 4 | 8.7% | -29.5% | +190.3% |
| Dec 2018 | Feb 2019 | 10 | 14.8% | +33.2% | +222.1% |
| Mar 2019 | Nov 2019 | 33 | 37.3% | -9.7% | +201.3% |
| Mar 2020 | Mar 2020 | 1 | 11.2% | +80.3% | +233.9% |
| Jun 2020 | Jun 2020 | 1 | 1.0% | +54.7% | +191.4% |
| Jul 2020 | Aug 2020 | 1 | 5.0% | +57.7% | +201.7% |
| Aug 2021 | Aug 2021 | 1 | 6.3% | +5.9% | +168.2% |
| Nov 2021 | Feb 2022 | 15 | 8.0% | -1.2% | +149.8% |
| Feb 2022 | Mar 2022 | 2 | 8.1% | +50.5% | +166.0% |
| Apr 2022 | Aug 2022 | 15 | 20.3% | +30.7% | +169.7% |
| Aug 2022 | Oct 2022 | 11 | 13.2% | +34.1% | +167.2% |
| Average | 13 | — | +13.9% | — |
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of Friday close, 2026-02-02